Hereditary gelsolin amyloidosis

Handbook of Clinical Neurology

Volumn 115, Issue , 2013, Pages 659-681

  Kiuru Enari, Sari ^a   Haltia, Matti ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Amyloid angiopathy; Corneal lattice dystrophy; Cutis laxa; Facial palsy; Familial amyloid polyneuropathy IV; Gelsolin; Gelsolin amyloidosis; Hereditary amyloidosis; Meretoja's disease; Peripheral neuropathy

Indexed keywords

AMYLOID; GELSOLIN;

AMYLOIDOSIS; ANIMAL; ARTICLE; CONGENITAL CORNEA DYSTROPHY; CORNEA LATTICE DYSTROPHY; CUTIS LAXA; FACIAL NERVE PARALYSIS; FAMILIAL AMYLOID POLYNEUROPATHY IV; FAMILIAL AMYLOIDOSIS; GELSOLIN AMYLOIDOSIS; GENETICS; HUMAN; MERETOJA SYNDROME; MERETOJA'S DISEASE; METABOLISM; PERIPHERAL NEUROPATHY; VASCULAR AMYLOIDOSIS;

AMYLOID ANGIOPATHY; CORNEAL LATTICE DYSTROPHY; CUTIS LAXA; FACIAL PALSY; FAMILIAL AMYLOID POLYNEUROPATHY IV; GELSOLIN; GELSOLIN AMYLOIDOSIS; HEREDITARY AMYLOIDOSIS; MERETOJA'S DISEASE; PERIPHERAL NEUROPATHY;

AMYLOID; AMYLOIDOSIS; ANIMALS; CORNEAL DYSTROPHIES, HEREDITARY; GELSOLIN; HUMANS;

EID: 84881522839     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52902-2.00039-4     Document Type: Chapter

References (133)

1. Akiya S., Nishio Y., Ibi K., et al. Lattice corneal dystrophy type II associated with familial amyloidosis, Finnish type (FAF). Ophthalmology 1996, 103:1106-1110.
2. Anan I., Kiuru-Enari S., Obayashi K., et al. Investigation of AGE, their receptor and NF-kB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis. Histol Histopathol 2010, 25:691-699.
3. Antequera D., Vargas T., Ugalde C., et al. Cytoplasmic gelsolin increases mitochondrial activity and reduces Aβ burden in a mouse model of Alzheimer's disease. Neurobiol Dis 2009, 36:42-50.
4. Ardalan M.R., Shoja M.M., Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant 2007, 22:272-275.
5. Ardalan M.R., Shoja M.M., Paunio T., et al. Hereditary gelsolin amyloidosis in Iran: the first report from the Middle East. XIth International Symposium on Amyloidosis 2007, 118-120. CRR Press, USA. M. Skinner, J.L. Berk, L.H. Connors (Eds.).
6. Asahina A., Yokoyama T., Ueda M., et al. Hereditary gelsolin amyloidosis: a new Japanese case with cutis laxa as a diagnostic clue. Acta Derm Venereol 2011, 91:201-203.
7. Baumann M., Kallijärvi J., Lankinen H., et al. Apolipoprotein E includes a binding site which is recognized by several amyloidogenic peptides. Biochem J 2000, 349:77-84.
8. Boysen G., Galassi G., Kamieniecka Z., et al. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry 1979, 42:1020-1030.
9. Brady S.T., Lasek R.J., Allen R.D., et al. Gelsolin inhibition of fast axonal transport indicates a requirement for actin microfilaments. Nature 1984, 310:56-58.
10. Bucki R., Leventhal I., Kulakowska A., et al. Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 2008, 9:541-551.
11. Bürmann J., Fassbender K., Henn W., et al. Neurologische Manifestationen der AGel-Amyloidose (Meretoja-Syndrom) bei einer deutschen Familie. Fortschr Neurol Psychiatr 2011, 79:238-241.
12. Carrwik C., Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome). Acta Ophthalmol (Copenh) 2009, 87:813-819.
13. Chastan N., Baert-Desurmont S., Saugier-Veber P., et al. Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the Asp187Tyr mutation in the GSN gene. Muscle Nerve 2006, 33:113-119.
14. 2+ stabilization. EMBO J 2001, 20:6277-6287.
15. Collan Y., Meretoja J. Inherited systemic amyloidosis (Finnish type): ultrastructure of the skin. Ann Clin Res 1978, 10:43-47.
16. Conceicão I., Sales-Luis M.L., de Carvalho M., et al. Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological findings. Muscle Nerve 2003, 28:715-721.
17. Contégal F., Bidot S., Thauvin C., et al. Finnish amyloid polyneuropathy in a French patient. Rev Neurol (Paris) 2006, 162:997-1001.
18. Darras B.T., Adelman L.S., Mora J.S., et al. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology 1986, 36:432-435.
19. de la Chapelle A., Kere J., Sack G.H., et al. Familial amyloidosis, Finnish type: G654->A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992, 1:898-901.
20. de la Chapelle A., Tolvanen R., Boysen G., et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992, 2:157-160.
21. Donders P.C., Blanksma L.J. Meretoja syndrome: lattice dystrophy of the cornea with hereditary generalized amyloidosis. Ophthalmologica 1979, 178:173-180.
22. Endres M., Fink K., Zhu J., et al. Neuroprotective effects of gelsolin during stroke. J Clin Invest 1999, 103:347-354.
23. Felix E.P.V., Jung L.S., Carvalho G.S., et al. Corneal lattice dystrophy type II-familial amyloid polyneuropathy type IV (gelsolin amyloidosis). Einstein 2008, 6:505-506.
24. Fernández A.L., Herreros J.M., Monzonis A.M., et al. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J 1997, 31:357-359.
25. Furukawa K., Fu W., Li Y., et al. The actin-severing protein gelsolin modulated calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci 1997, 17:8178-8186.
26. Ghiso J., Haltia M., Prelli F., et al. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990, 272:827-830.
27. Gorevic P.D., Munoz P.C., Gorgone G., et al. Amyloidosis due to a mutation of the gelsolin gene in an American family with corneal lattice dystrophy type II. NEJM 1991, 325:1780-1785.
28. Haltia M., Ghiso J., Prelli F., et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990, 136:1223-1228.
29. Haltia M., Prelli F., Ghiso J., et al. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun 1990, 167:927-932.
30. Haltia M., Ghiso J., Wisniewski T., et al. Gelsolin variant and β-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 1991, 12:313-316.
31. Haltia M., Levy E., Meretoja J., et al. Gelsolin gene mutation-at codon 187 in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 1992, 42:357-359.
32. Hanyu N., Ikeda S., Nakadai A., et al. Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesions. Ann Neurol 1989, 25:340-350.
33. 187->Asn mutation of gelsolin with the disease in three large families. Am J Hum Genet 1991, 49:522-528.
34. Hornigold R., Patel A.V., Ward V.M., et al. Familial systemic amyloidosis associated with bilateral sensorineural hearing loss and bilateral facial palsies. J Laryngol Otol 2006, 120:778-780.
35. Huerva V., Velasco A., Sánchez M.C., et al. Lattice corneal dystrophy type II: Clinical, pathologic, and molecular study in a Spanish family. Eur J Ophthalmol 2007, 17:424-429.
36. Huff M., Balch W., Kelly J.W. Pathological and functional amyloid formation orchestrated by the secretory pathway. Curr Opin Struct Biol 2003, 13:674-682.
37. Ikeda M., Mizushima K., Fujita Y., et al. Familial amyloid polyneuropathy (Finnish type) in a Japanese family: clinical features and immunocytochemical studies. J Neurol Sci 2007, 252:4-8.
38. Juusela P., Tanskanen M., Nieminen A., et al. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome. Clin Rheumatol 2009, 28:1351-1354.
39. Juusela P., Tanskanen M., Nieminen A., et al. Xerostomia in hereditary gelsolin amyloidosis. Amyloid 2013, 20:39-44.
40. Kangas H., Paunio T., Kalkkinen N., et al. In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 1996, 5:1237-1243.
41. Kangas H., Ulmanen I., Paunio T., et al. Functional consequences of amyloidosis mutation for gelsolin polypeptide- analysis of gelsolin-actin interaction and gelsolin processing in gelsolin knock-out fibroblasts. FEBS Lett 1999, 454:233-239.
42. Kangas H., Seidah N.G., Paunio T. Role of proprotein convertases in the pathogenic processing of the amyloidosis-associated form of secretory gelsolin. Amyloid 2002, 9:83-87.
43. Kiuru S. Familial amyloidosis of the Finnish type (FAF): a clinical study of 30 patients. Acta Neurol Scand 1992, 86:346-353.
44. Kiuru S. Review: gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998, 5:55-66.
45. Kiuru S., Seppäläinen A.M. Neuropathy in familial amyloidosis, Finnish type (FAF): electrophysiological studies. Muscle Nerve 1994, 17:299-304.
46. Kiuru S., Matikainen E., Kupari M., et al. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994, 126:40-48.
47. Kiuru S., Seppäläinen A.M., Salonen O., et al. CNS abnormalities in patients with familial amyloidosis of the Finnish type (FAF). Amyloid 1995, 1:80-89.
48. Kiuru S., Nieminen T., Partinen M. Obstructive sleep apnea syndrome in hereditary gelsolin related amyloidosis. J Sleep Res 1999, 8:143-149.
49. Kiuru S., Salonen O., Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol 1999, 45:305-311.
50. Kiuru S., Javela K., Somer H., et al. Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis. Thromb Haemost 2000, 83:491-495.
51. Kiuru-Enari S., Haltia M. Perinnöllinen gelsoliiniamyloidoosi-40 vuotta Meretojan tautia. Duodecim 2010, 126:67-77. (in Finnish).
52. Kiuru-Enari S., Somer H., Seppäläinen A.M., et al. Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol 2002, 61:565-571.
53. Kiuru-Enari S., Keski-Oja J., Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol 2005, 152:250-257.
54. Kivelä T., Tarkkanen A., McLean, et al. Immunohistochemical analysis of lattice corneal dystrophies types I and II. Br J Ophthalmol 1993, 77:799-804.
55. Kivelä T., Tarkkanen A., Frangione B., et al. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci 1994, 35:3759-3769.
56. Klaus E., Freyberger E., Kavka G., et al. Familiäres Vorkommen von bulbärparalytischer Form der amyotrophischen Lateralsklerose mit gittriger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Psychiatr Neurol (Basel) 1959, 138:79-97.
57. Koskelainen S. Suomalaisen gelsoliiniamyloidoosin banaanikärpäsmalli 2007, Pro gradu, Helsingin yliopisto, [in Finnish].
58. Kwiatkowski D.J. Functions of gelsolin: motility, signalling, apoptosis, cancer. Curr Opin Cell Biol 1999, 1:103-108.
59. Kwiatkowski D.J., Stossel T.P., Orkin, et al. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986, 323:455-456.
60. Kwiatkowski D.J., Mehl R., Izumo S., et al. Muscle is the major source of plasma gelsolin. J Biol Chem 1988, 263:8239-8243.
61. Laine A., Kääriäinen H., Notkola I.L., et al. Perinnöllinen Meretojan tauti. Runsas oirekirjo heikentää elämänlaatua ja lisää terveyspalvelujen käyttöä. Suom Lääkäril 2010, 16:1417-1424. [in Finnish].
62. Lee P.S., Bhan I., Thadhani R. The potential role of plasma gelsolin in dialysis-related protein-energy wasting. Blood Purif 2010, 29:99-101.
63. Levy E., Haltia M., Fernandez-Madrid I., et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990, 172:1865-1867.
64. Loeffler K.U., Edvard D.P., Tso M.O.M. An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis. Am J Ophthalmol 1992, 11:547-554.
65. Lu M., Witke W., Kwiatkoski D.J., et al. Delayed retraction of filopodia in gelsolin null mice. J Cell Biol 1997, 138:1279-1287.
66. Lüttmann R.J., Teismann I., Husstedt I.W., et al. Hereditary amyloidosis of the Finnish type in a German family: clinical and electrophysiological presentation. Muscle Nerve 2010, 41:679-684.
67. Mahalka A.K., Maury C.P.J., Kinnunen P.K.J. 1-Palmitoyl-2-(9'-oxononanoyl)-sn-glycero-3-phosphocholine, an oxidized phospholipid, accelerates Finnish type familial gelsolin amyloidosis in vitro. Biochemistry 2011, 50:4877-4889.
68. Makioka K., Ikeda M., Ikeda Y., et al. Familial amyloid polyneuropathy (Finnish type) presenting multiple cranial nerve deficits with carpal tunnel syndrome and orthostatic hypotension. Neurol Res 2010, 32:472-475.
69. Makishita H., Ikeda S., Yazaki M., et al. Postmortem findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid 1996, 3:132-139.
70. Maury C.P.J. Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 1991, 64:400-404.
71. Maury C.P.J. Homozygous familial amyloidosis, Finnish type: demonstration of glomerular gelsolin-derived amyloid and non-amyloid tubular gelsolin. Clin Nephrol 1993, 40:53-56.
72. Maury C.P.J., Baumann M. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990, 1096:84-86.
73. Maury C.P.J., Rossi H. Demonstration of a circulating 65K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem Biophys Res Commun 1993, 191:41-44.
74. Maury C.P.J., Alli K., Baumann M. Finnish hereditary amyloidosis: Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett 1990, 260:85-87.
75. Maury C.P.J., Kere J., Tolvanen R., et al. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 1990, 276:75-77.
76. Maury C.P.J., Kere J., Tolvanen R., et al. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 1992, 13:902-903.
77. Maury C.P.J., Sletten K., Totty N., et al. Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications. Lab Invest 1997, 77:299-304.
78. Maury C.P.J., Liljeström M., Boysen G., et al. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol 2000, 53:95-99.
79. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms: a previously unrecognized heritable syndrome. Ann Clin Res 1969, 1:314-324.
80. Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica 1972, 165:15-37.
81. Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet 1973, 4:173-185.
82. Meretoja J. Inherited systemic amyloidosis with corneal lattice dystrophy 1973, Academic dissertation. University of Helsinki. Vammalan kirjapaino, Vammala.
83. Meretoja J. Tautiperintöämme: suomalainen amyloiditauti. Suom lääkäril 1976, 31:2234-2236. [in Finnish].
84. Meretoja J., Tarkkanen A. Pseudoexfoliation syndrome in familial systemic amyloidosis with lattice corneal dystrophy. Ophthalmic Res 1975, 7:194-203.
85. Meretoja J., Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation: report of three cases. Acta Pathol Microbiol Scand [A] 1971, 79:432-440.
86. Meretoja J., Jokinen E.J., Collan Y., et al. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. Acta Pathol Microbiol Scand [A] 1972, 80:228-238.
87. Molloy S.S., Anderson E.D., Jean F., et al. Bi-cyclin the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol 1999, 91:28-35.
88. Page L.J., Suk J.Y., Huff M., et al. Metalloprotease cleavage triggers gelsolin amyloidosis. EMBO J 2005, 24:4124-4132.
89. Page L.J., Suk J.Y., Bazhenova L., et al. Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. PNAS 2009, 106:11125-11130.
90. Papathanassiou M., Liarakos V.S., Vaikousis E., et al. Corneal melt in lattice corneal dystrophy type II after cataract surgery. J Cataract Refract Surg 2009, 35:185-189.
91. 654->A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992, 13:237-239.
92. Paunio T., Kangas H., Kalkkinen N., et al. Toward understanding of the pathogenetic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal fragment. Hum Mol Genet 1994, 3:2223-2229.
93. Paunio T., Kiuru S., Karonen S.L., et al. Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid 1994, 1:80-89.
94. Paunio T., Sunada Y., Kiuru S., et al. Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G654A) of gelsolin in Finland and Japan. Hum Mutat 1995, 6:60-65.
95. Paunio T., Kangas H., Kiuru S., et al. Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis. FEBS Lett 1997, 406:49-55.
96. Paunio T., Kangas H., Heinonen O., et al. Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J Biol Chem 1998, 273:16319-16324.
97. Pihlamaa T., Rautio J., Kiuru-Enari S., et al. Gelsolin amyloidosis as a cause of early aging and progressive facial paralysis. Plast Reconstr Surg 2011, 127:2342-2351.
98. Purcell J.J., Rodriques M., Chishti I., et al. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 1983, 90:1512-1517.
99. Reilly M.M., Brueton L., Sweeney M., et al. Gelsolin-related familial amyloid polyneuropathy in a British patient. Muscle Nerve Suppl 1998, 7:S133.
100. Rintala A.E., Alanko A., Mäkinen J., et al. Primary hereditary systemic amyloidosis (Meretoja's syndrome): clinical features and treatment by plastic surgery. Scand J Plast Reconstr Surg 1988, 22:141-145.
101. Rodriques M.M., Rajagopalan S., Jones K., et al. Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies. Am J Ophthalmol 1993, 115:644-652.
102. Rosenberg M.E., Tervo T.M.T., Gallar J., et al. Corneal morphology and sensitivity in lattice dystrophy type II (Familial amyloidosis, Finnish type). Invest Ophthalmol Vis Sci 2001, 42:634-641.
103. Rothstein A., Auran J.D., Wittpenn J.R., et al. Confocal microscopy in Meretoja Syndrome. Cornea 2002, 21:364-367.
104. Sack Gh., Dumars K.W., Gummerson K.S., et al. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J 1981, 149:239-247.
105. Sethi S., Theis J.D., Quint P., et al. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis 2013, 61:161-166.
106. Shoja M.M., Ardalan M.R., Tubbs R.S., et al. Outcome of renal transplant in hereditary gelsolin amyloidosis. Am J Med Sci 2009, 337:370-372.
107. Shokouhi G., Khosroshahi H.T. Ardalan-Shoja-Kiuru syndrome: hereditary gelsolin amyloidosis plus retinitis pigmentosa. Nephrol Dial Transplant 2008, 23:1071.
108. Solari H.P., Ventura M.P., Antecka E., et al. Danish-type gelsolin amyloidosis in a Brazilian family: case reports. Arq Bras Oftalmol 2011, 74:286-288.
109. Solomon J.P., Page L.J., Balch W.E., et al. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 2012, 47:282-296.
110. Soto C., Castaño E.M., Prelli F., et al. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett 1995, 371:110-114.
111. Spinardi L., Witke W. Gelsolin and diseases. Subcell Biochem 2007, 45:55-69.
112. Spuler S., Emslie-Smith A., Engel A.G. Amyloid myopathy: an underdiagnosed entity. Ann Neurol 1998, 43:719-728.
113. Starck T., Kenyon K.R., Hanninen L.A., et al. Clinical and histopathological studies of two families with corneal lattice dystrophy and familial amyloidosis (Meretoja syndrome). Ophthalmology 1991, 98:1197-1206.
114. Steiner R.D., Paunio T., Uemichi T., et al. Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAF). Hum Genet 1995, 95:327-330.
115. Stewart H.S., Parveen R., Ridgway A.E., et al. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Br J Ophthalmol 2000, 84:390-394.
116. Su A.I., Wiltshire T., Batalov S., et al. A gene atlas of the mouse and human protein-encoding transcriptosomes. Proc Natl Acad Sci U S A 2004, 101:6062-6067.
117. Suk J.Y., Zhang F., Balch W.E., et al. Heparin accelerates gelsolin amyloidogenesis. Biochemistry 2006, 45:2234-2242.
118. Sunada Y., Shimizu T., Nakase H., et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993, 33:57-62.
119. Sunada Y., Sakurai T., Nonomura Y., et al. Abnormal gelsolin fragments in the plasma of patients with familial amyloidosis of the Finnish type. Amyloid and Amyloidosis 1994, 623-625. Parthenon Publishing, New York. R. Kisilevsky, M.D. Benson, B. Frangione (Eds.).
120. Tanaka J., Sobue K. Localization and characterization of gelsolin in nervous tissue: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 1994, 14:1038-1052.
121. Tanaka J., Kira M., Sobue K. Gelsolin is localized in neuronal growth cones. Dev Brain Res 1993, 76:268-271.
122. Tanskanen M., Paetau A., Salonen O., et al. Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report. Amyloid 2007, 14:89-95.
123. Van Gerpen J.A., Dyck P.J.B., Dyck P.J. Cutaneous T-cell lymphoma imitating gelsolin amyloidosis. Neurology 2003, 60:861.
124. Vargas T., Antequera D., Ugalde C., et al. Gelsolin restores A beta-induced alterations in choroid plexus epithelium. J Biomed Biotechnol 2010, 805405. 10.1155/2010/805405.
125. Vouyiouklis D.A., Brophy P.J. A novel gelsolin isoform expressed by oligodendrocytes in the central nervous system. J Neurochem 1997, 69:995-1005.
126. Vrabec F.R. Etude neurohistologique d'un cas de dystrophie grillagée de la cornée. Ophthalmologica 1957, 133:160-169.
127. Way M., Weeds A. Nucleotide sequence of pig plasma gelsolin: comparison of protein sequence with human gelsolin and other actin-severing proteins shows strong homologies and evidence for large internal repeats. J Mol Biol 1988, 203:1127-1133.
128. Weeds A., Gooch J., McLaughlin P., et al. Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 1993, 335:119-123.
129. Westberg J., Zhang K., Andersson L. Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin. FASEB J 1999, 13:1621-1626.
130. Winkelman J.E., Delleman J.W., Ansink B.J.J. Ein hereditäres Syndrom, bestehend aus peripherer Polyneuropathie, Hautveränderungen und gittriger Dystrophie der Hornhaut. Klin Monatsbl Augenheilkd 1971, 159:618-623.
131. Wisniewski T., Haltia M., Ghiso J., et al. Lewy bodies are immunoreactive with antibodies to gelsolin related amyloid-Finnish type. Am J Pathol 1991, 138:1077-1083.
132. Yazaki M., Makishita H., Yazawa M., et al. Clinicopathological study of type IV familial amyloid polyneuropathy in Japan. Amyloid and Amyloidosis 1994, 688-690. Parthenon Publishing, New York. R. Kisilevsky, M.D. Benson, B. Frangione (Eds.).
133. Yin H., Kwiatkowski D.J., Mole J.E., et al. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984, 259:5271-5276.